Electronic health records (EHRs) can show when long-term conditions go into remission, but how remission is measured varies a lot between studies.
The review looked at 91 studies asking how remission is recorded in EHRs for long-term diseases, including three studies about multiple sclerosis (MS). Researchers used many different ways to say someone was in remission, such as medical codes, rating scales (questionnaires), lab results, no symptoms, no hospital visits, or stopping medicines. Different studies used different rules and time periods, so one study's “remission” could mean something different than another's. Because definitions differ, it is hard to compare results from different hospitals or studies without a common definition. The authors suggest making clearer, shared rules to track remission better in EHRs so doctors and patients can compare progress more reliably.
People with MS and their caregivers should care because EHRs are often used to check how well treatments are working and whether symptoms improve or stop. If your medical record uses different signs to say you are in remission, it could change what your doctor thinks about your progress—like comparing grades from different schools that use different scoring rules. Clinicians and MS care teams can use clearer, shared definitions to track patient changes across visits and hospitals, making treatment decisions more consistent. Researchers and hospitals benefit because standard definitions let them compare results from different places and learn what treatments really help. As a patient or caregiver, knowing how remission is defined at your clinic helps you understand test results, medication changes, and what follow-up to expect.
Only three of the 91 studies specifically looked at MS, so the findings may not fully represent how remission works for everyone with MS. The included studies used many different measures and follow-up times, so results are not always comparable or generalizable to every clinic or country. This review did not test new rules in real health systems, so we do not yet know which exact definition of remission works best for MS in everyday care.
AI-generated summary — for informational purposes only, not medical advice
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More7/1/2026
Study shows aerobic exercise alters brain circuits linked to automatic body control and fatigue in M
Read More7/1/2026
A simple eye scan and a blood test for sGFAP together help identify people with MS at higher risk of
Read More6/1/2026
Emerging MS therapies aim to slow long-term worsening, target a possible viral trigger, and repair n
Read More5/19/2026
Study finds immune protein C4 is made in certain white blood cells and linked to gene copies; this o
Read More5/19/2026
This review finds brain-focused magnetic therapy (TMS) may ease movement, stiffness, fatigue, and th
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of medical Internet research often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.